Shoppers of biotech headlines are spotting a fresh partnership: Waiv, the Paris-born AI pathology specialist, has teamed up with Daiichi Sankyo to hunt for digital biomarkers that could predict patient response to antibody‑drug conjugates , a move that matters because ADCs need clever screening when trial sizes are tiny. Essential…

Shoppers and food businesses in Dubai are getting a safety upgrade as Dubai Municipality opens ViruGenetics, the UAE’s first dedicated lab using cutting‑edge genomic tools to spot foodborne viruses , a move that speeds up testing, boosts confidence in local produce, and helps authorities act faster on contamination. Essential Takeaways…

Shoppers of talent and capacity are watching big pharmas double down in North America: Amgen is ploughing another $300m into its Puerto Rico biologics plant while Sanofi is committing $294m to grow an AI centre in Toronto , moves that aim to secure supply chains and speed drug development. Essential…

Shoppers and investors are circling back to cannabis stocks as rescheduling gains steam, US multi-state operators are reporting solid quarters and operational growth, which matters for anyone weighing cannabis shares in 2026. Here’s a clear, practical look at the names to watch and why their business wins could translate to…

Shoppers are noticing headlines about edited fish, and producers are quietly preparing: genome editing is moving from lab curiosity to commercial tool in aquaculture, promising faster breeding gains, disease resistance and environmental safeguards that matter for supply, price and sustainability. Essential Takeaways Precision advantage: Genome editing (SDN‑1) makes tiny, natural‑looking…

Shoppers and clinicians alike are turning to a new blood test that maps the social life of cells around a cancerous tumour, offering a non-invasive window into the tumour microenvironment and clues about which therapies might work best. Researchers at Stanford and the Mayo Clinic say it could change how…

Shoppers of prediction markets and investors are leaning into cloud winners: Alphabet and Meta look well supported right now, thanks to soaring cloud revenues and strategic capex moves that matter for infrastructure and geopolitics. Here’s what to watch and how it could shape stock outcomes. Essential Takeaways Strong cloud momentum:…

Shoppers are turning to smarter home protection as insurers and tech firms partner to stop disasters before they start; Nationwide and Whisker Labs are offering sensors and AI-driven alerts to spot electrical and freeze risks early, helping homeowners avoid expensive fire and water claims. Essential Takeaways Free or discounted devices:…

Shoppers and CIOs alike are switching to software-first cybersecurity as organisations embrace cloud, edge and hybrid stacks; demand is soaring because SDS delivers centralised control, faster response and better scalability, important for IT, finance and healthcare teams looking to reduce breach risk. Essential Takeaways Market growth: The software defined security…

Shoppers of market innovation have noticed a new front in trading: the NYSE has filed an immediately effective rule change to let certain securities settle in tokenised form, a move that could reshape post-trade plumbing for mainstream stocks and ETFs and matters for investors, brokers and market infrastructure. Essential takeaways…

Shoppers and investors are turning to AI-powered healthcare tools as inflation and macro uncertainty bite; three stocks , GeneDx, Medtronic and Stryker , illustrate how genomics, surgical robotics and hospital platforms could reshape diagnostics, treatment and research. Here’s a clear-eyed look at what each company actually does and why it…

Shoppers in biotech terms are betting on a tiny chip to deliver big protein answers , Pumpkinseed, a Stanford spinout, has just raised $20 million to push its deSIPHR Raman‑based platform from peptides toward full‑length protein sequencing, promising richer, faster functional data that could reshape drug discovery and biosecurity. Essential…